96 related articles for article (PubMed ID: 8246611)
1. Are we curing acute myelogenous leukemia?
Ben-Bassat I; Bandini G; Rosti G; Gale RP
Leuk Res; 1993 Dec; 17(12):1071-2. PubMed ID: 8246611
[No Abstract] [Full Text] [Related]
2. Relapse and death during first remission in acute myeloid leukemia.
Yanada M; Garcia-Manero G; Borthakur G; Ravandi F; Kantarjian H; Estey E
Haematologica; 2008 Apr; 93(4):633-4. PubMed ID: 18379012
[No Abstract] [Full Text] [Related]
3. Intensive sequential post-induction therapy for adults with acute myelogenous leukemia in first remission: long-term follow-up and results.
Ino T; Kojima H; Miyazaki H; Maruyama F; Sobue R; Okamoto M; Matsui T; Shimizu K; Ezaki K; Hirano M
Leuk Res; 1992; 16(6-7):577-84. PubMed ID: 1635375
[TBL] [Abstract][Full Text] [Related]
4. [Survival in adults with acute myelogenous leukemia].
Tangen JM; Fløisand Y; Foss-Abrahamsen J; Haukås E; Naess IA; Skjelbakken T
Tidsskr Nor Laegeforen; 2008 May; 128(10):1164-7. PubMed ID: 18480864
[TBL] [Abstract][Full Text] [Related]
5. Intensive chemotherapy for acute myelogenous leukemia.
Gale RP; Foon KA; Cline MJ; Zighelboim J
Ann Intern Med; 1981 Jun; 94(6):753-7. PubMed ID: 6940466
[TBL] [Abstract][Full Text] [Related]
6. [Acute myelogenous leukemia in elderly].
Mori M
Rinsho Ketsueki; 1999 Feb; 40(2):77-80. PubMed ID: 10199195
[No Abstract] [Full Text] [Related]
7. Etoposide in remission induction of adult acute myeloid leukemia.
Leoni F; Ciolli S; Patriarchi S; Morfini M; Rossi Ferrini P
Acta Haematol; 1990; 83(2):82-5. PubMed ID: 2106200
[TBL] [Abstract][Full Text] [Related]
8. [Acute myeloid leukemia].
Büchner T
Internist (Berl); 1993 Jun; 34(6):511-7. PubMed ID: 8335440
[No Abstract] [Full Text] [Related]
9. Postremission therapy with two different dose regimens of cytarabine in adults with acute myelogenous leukemia.
Shpilberg O; Haddad N; Sofer O; Raanani P; Berkowicz M; Chetrit A; Carter A; Ramot B; Tatarski I; Ben-Bassat I
Leuk Res; 1995 Dec; 19(12):893-7. PubMed ID: 8632657
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic versus autologous bone marrow transplantation (BMT) versus intensive consolidation in acute myelogenous leukemia (AML) in first remission. An EORTC-Gimema phase III trial (AML8 A). The EORTC Leukemia Cooperative Group and the GIMEMA Group.
Zittoun R; Mandelli F; Willemze R; de Witte T; Tura S; Ferrini PR; Stryckmans P; Gattringer C; Petti MC; Solbu G
Leukemia; 1992; 6 Suppl 2():114-5. PubMed ID: 1578909
[No Abstract] [Full Text] [Related]
11. Follow-up 26 years after treatment for acute myelogenous leukemia.
Clift RA; Thomas ED;
N Engl J Med; 2004 Dec; 351(23):2456-7. PubMed ID: 15575071
[No Abstract] [Full Text] [Related]
12. Is there a role for postremission therapy in older adults with acute myelogenous leukemia (AML)?
Rowe JM
Leukemia; 2005 Aug; 19(8):1324-7. PubMed ID: 15944718
[No Abstract] [Full Text] [Related]
13. Treatment of adult acute myelogenous leukemia: a pilot study at Chulalongkorn Hospital.
Intragumtornchai T; Sucharitchan P; Swasdikul D; Mahasandhana S; Watananukul P
J Med Assoc Thai; 1991 Jul; 74(7):265-71. PubMed ID: 1765741
[TBL] [Abstract][Full Text] [Related]
14. Improved prospects for long-term survival in adults with acute myelogenous leukemia.
Keating MJ; McCredie KB; Bodey GP; Smith TL; Gehan E; Freireich EJ
JAMA; 1982 Nov; 248(19):2481-6. PubMed ID: 6957624
[TBL] [Abstract][Full Text] [Related]
15. [II. Leukemia in the elderly, secondary, recurrent and refractory leukemia, chloroma].
Jehn U; Dengler R; Petrides PE
Internist (Berl); 1996 Jun; 37(6):669-77. PubMed ID: 8768004
[No Abstract] [Full Text] [Related]
16. Effect of induction cytarabine dose intensity on long-term survival in acute myelogenous leukemia: results of a randomized, controlled study.
Schiller G; Nimer S; Gajewski J; Lee M; Ho W; Territo M; Champlin R
Leuk Lymphoma; 1993 Sep; 11(1-2):69-77. PubMed ID: 8220156
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of acute leukemia in adults].
Lechner K
Wien Med Wochenschr; 1991; 141(9-10):180-90. PubMed ID: 1949839
[TBL] [Abstract][Full Text] [Related]
18. Autologous bone marrow transplantation in late first complete remission improves outcome in acute myelogenous leukemia.
Miggiano MC; Gherlinzoni F; Rosti G; Bandini G; Visani G; Fiacchini M; Ricci P; Testoni N; Motta MR; Geromin A; Rizzi S; Belardinelli A; Mangianti S; Manfroi S; Tura S
Leukemia; 1996 Mar; 10(3):402-9. PubMed ID: 8642854
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy in acute myelogenous leukemia: high dose, higher expectations?
Berman E
J Clin Oncol; 1995 Jan; 13(1):1-4. PubMed ID: 7799008
[No Abstract] [Full Text] [Related]
20. Homoharringtonine, aclarubicin and cytarabine (HAA) regimen as the first course of induction therapy is highly effective for acute myeloid leukemia with t (8;21).
Zhu HH; Jiang H; Jiang Q; Jia JS; Qin YZ; Huang XJ
Leuk Res; 2016 May; 44():40-4. PubMed ID: 26994850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
